Bb Biotech as of June 30, 2018
Portfolio Holdings for Bb Biotech
Bb Biotech holds 32 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals (IONS) | 10.4 | $361M | 8.7M | 41.67 | |
| Neurocrine Biosciences (NBIX) | 9.4 | $326M | 3.3M | 98.24 | |
| Celgene Corporation | 7.6 | $264M | 3.3M | 79.42 | |
| Incyte Corporation (INCY) | 7.3 | $252M | 3.8M | 67.00 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.9 | $238M | 1.4M | 169.96 | |
| Agios Pharmaceuticals (AGIO) | 5.3 | $185M | 2.2M | 84.23 | |
| Radius Health | 5.3 | $183M | 6.2M | 29.47 | |
| Gilead Sciences (GILD) | 4.9 | $168M | 2.4M | 70.84 | |
| Sage Therapeutics (SAGE) | 4.8 | $168M | 1.1M | 156.53 | |
| Alexion Pharmaceuticals | 4.8 | $167M | 1.3M | 124.15 | |
| Halozyme Therapeutics (HALO) | 4.0 | $139M | 8.2M | 16.87 | |
| Esperion Therapeutics (ESPR) | 3.6 | $125M | 3.2M | 39.19 | |
| Alnylam Pharmaceuticals (ALNY) | 3.2 | $112M | 1.1M | 98.49 | |
| Tesaro | 3.1 | $108M | 2.4M | 44.47 | |
| Regeneron Pharmaceuticals (REGN) | 2.7 | $93M | 270k | 344.99 | |
| Myovant Sciences | 2.3 | $80M | 3.5M | 22.87 | |
| Akcea Therapeutics Inc equities | 1.7 | $59M | 2.5M | 23.71 | |
| Macrogenics (MGNX) | 1.6 | $55M | 2.7M | 20.65 | |
| Voyager Therapeutics (VYGR) | 1.4 | $50M | 2.5M | 19.54 | |
| Intercept Pharmaceuticals In | 1.3 | $46M | 546k | 83.91 | |
| Wave Life Sciences (WVE) | 1.3 | $44M | 1.1M | 38.25 | |
| Intra Cellular Therapies (ITCI) | 1.1 | $39M | 2.2M | 17.67 | |
| Argenx Se (ARGX) | 1.1 | $37M | 449k | 82.86 | |
| Alder Biopharmaceuticals | 1.0 | $36M | 2.3M | 15.80 | |
| Nektar Therapeutics | 0.7 | $26M | 525k | 48.83 | |
| Myokardia | 0.7 | $24M | 480k | 49.65 | |
| Exelixis (EXEL) | 0.7 | $23M | 1.1M | 21.52 | |
| Five Prime Therapeutics | 0.5 | $16M | 978k | 15.81 | |
| G1 Therapeutics | 0.4 | $15M | 353k | 43.46 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.3 | $12M | 2.3M | 5.20 | |
| Novavax | 0.3 | $11M | 8.3M | 1.34 | |
| Achillion Pharmaceuticals | 0.1 | $3.6M | 1.3M | 2.83 |
